Cargando…

Dysregulation of Cell Survival in Diffuse Large B Cell Lymphoma: Mechanisms and Therapeutic Targets

Diffuse large B cell lymphoma (DLBCL) is the most common type of lymphoma worldwide, representing 30–40% of non-Hodgkin lymphomas, and is clinically aggressive. Although more than half of patients with DLBCL are cured by using standard first-line immunochemotherapy, the remaining patients are refrac...

Descripción completa

Detalles Bibliográficos
Autores principales:	Miao, Yi, Medeiros, L. Jeffrey, Xu-Monette, Zijun Y., Li, Jianyong, Young, Ken H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6406015/ https://www.ncbi.nlm.nih.gov/pubmed/30881917 http://dx.doi.org/10.3389/fonc.2019.00107

Ejemplares similares

Cancer Immunotherapy in Diffuse Large B-Cell Lymphoma
por: Zhang, Jun, et al.
Publicado: (2018)

The progress of novel strategies on immune-based therapy in relapsed or refractory diffuse large B-cell lymphoma
por: Lu, Tingxun, et al.
Publicado: (2023)

Mechanisms of ferroptosis and targeted therapeutic approaches in lymphoma
por: Yu, Tiantian, et al.
Publicado: (2023)

Dysregulated CXCR4 expression promotes lymphoma cell survival and independently predicts disease progression in germinal center B-cell-like diffuse large B-cell lymphoma
por: Chen, Jiayu, et al.
Publicado: (2015)

Expression and Prognostic Significance of PD-L2 in Diffuse Large B-Cell Lymphoma
por: Gu, Qianhui, et al.
Publicado: (2021)

Secondary Diffuse Large B-cell Lymphoma Mimicking Meningioma
por: Garcia-Grimshaw, Miguel, et al.
Publicado: (2019)

Molecular Heterogeneity in Localized Diffuse Large B-Cell Lymphoma
por: Qin, Wei, et al.
Publicado: (2021)

Bilateral Primary testicular diffuse large B-CELL lymphoma
por: Trama, Francesco, et al.
Publicado: (2021)

Metabolic Reprogramming and Potential Therapeutic Targets in Lymphoma
por: Pang, Yuyang, et al.
Publicado: (2023)

DNA Copy Number Changes in Diffuse Large B Cell Lymphomas
por: Cascione, Luciano, et al.
Publicado: (2020)

Development and Validation of a Novel Risk Stratification Model for Cancer-Specific Survival in Diffuse Large B-Cell Lymphoma
por: Zhong, Qiaofeng, et al.
Publicado: (2021)

Effect of infection with hepatitis B virus on the survival outcome of diffuse large B-cell lymphoma in the prophylactic antiviral era
por: Nuersulitan, Reyizha, et al.
Publicado: (2022)

Mutational Profile and Clonal Evolution of Relapsed/Refractory Diffuse Large B-Cell Lymphoma
por: Lee, Boram, et al.
Publicado: (2021)

Targeting the hexosamine biosynthetic pathway and O-linked N-acetylglucosamine cycling for therapeutic and imaging capabilities in diffuse large B-cell lymphoma
por: Pham, Lan V., et al.
Publicado: (2016)

Composite Diffuse Large B-cell and Mantle Cell Lymphoma: A Case Report
por: Mohammad, Farhan, et al.
Publicado: (2017)

RelA NF-κB subunit activation as a therapeutic target in diffuse large B-cell lymphoma
por: Zhang, Mingzhi, et al.
Publicado: (2016)

Genomic Mutation Profile of Primary Gastrointestinal Diffuse Large B-Cell Lymphoma
por: Li, Peifeng, et al.
Publicado: (2021)

Diffuse large B-cell lymphoma presenting as LUTS: Clinical practice points
por: Lokeshwar, Soum D., et al.
Publicado: (2021)

Chronic Heel Pain Found to Be Diffuse Large B-cell Lymphoma of the Calcaneus
por: Horner, Kevin J, et al.
Publicado: (2022)

Real-world outcomes of diffuse large B-cell lymphoma in the biosimilar era
por: Nair, Reena, et al.
Publicado: (2023)

miRNome expression analysis in canine diffuse large B-cell lymphoma
por: Elshafie, Nelly O., et al.
Publicado: (2023)

New treatment options in elderly patients with Diffuse Large B-cell Lymphoma
por: Arcari, Annalisa, et al.
Publicado: (2023)

Hematolymphoid tumor of prostate: Diffuse large B cell lymphoma case report
por: Ochirjav, Enkhee, et al.
Publicado: (2023)

The Roles of Exosomal microRNAs in Diffuse Large B-Cell Lymphoma: Diagnosis, Prognosis, Clinical Application, and Biomolecular Mechanisms
por: Yazdanparast, Somayeh, et al.
Publicado: (2022)

NTRK fusion protein expression is absent in a large cohort of diffuse large B-cell lymphoma
por: Ghandili, Susanne, et al.
Publicado: (2023)

The Addition of Ferritin Enhanced the Prognostic Value of International Prognostic Index in Diffuse Large B‐Cell Lymphoma
por: Shen, Ziyuan, et al.
Publicado: (2022)

Diffuse Large B-Cell Lymphoma: Clinical Presentation and Treatment Outcomes From the OncoCollect Lymphoma Registry
por: Nair, Reena, et al.
Publicado: (2022)

Nomogram for Predicting the Overall Survival of Adult Patients With Primary Gastrointestinal Diffuse Large B Cell Lymphoma: A SEER- Based Study
por: Wang, Jing, et al.
Publicado: (2020)

Risk Stratification Using Multivariable Fractional Polynomials in Diffuse Large B-Cell Lymphoma
por: Roh, Jin, et al.
Publicado: (2020)

Consecutive Hypoalbuminemia Predicts Inferior Outcome in Patients With Diffuse Large B-Cell Lymphoma
por: Wei, Xiaolei, et al.
Publicado: (2021)

Plasma Metabolites Forecast Occurrence and Prognosis for Patients With Diffuse Large B-Cell Lymphoma
por: Fei, Fei, et al.
Publicado: (2022)

Primary diffuse large B-Cell lymphoma of the female urethra: A case report
por: Boughaleb, Abdelmounim, et al.
Publicado: (2023)

The Application of the Lymphoma International Prognostic Index to Predict Venous Thromboembolic Events in Diffuse Large B-Cell Lymphoma Patients
por: Abdel-Razeq, Hikmat, et al.
Publicado: (2021)

Development and validation of nomograms by radiomic features on ultrasound imaging for predicting overall survival in patients with primary nodal diffuse large B-cell lymphoma
por: Deng, Hongyan, et al.
Publicado: (2022)

Metabolic bulk volume predicts survival in a homogeneous cohort of stage II/III diffuse large B-cell lymphoma patients undergoing R-CHOP treatment
por: Jin, Hyun, et al.
Publicado: (2023)

Evidence for IL-35 Expression in Diffuse Large B-Cell Lymphoma and Impact on the Patient's Prognosis
por: Larousserie, Frédérique, et al.
Publicado: (2019)

Matrix Metallopeptidase 14: A Candidate Prognostic Biomarker for Diffuse Large B-Cell Lymphoma
por: Yin, Chengliang, et al.
Publicado: (2020)

The Prognostic Value of Blood-Based Biomarkers in Patients With Testicular Diffuse Large B-Cell Lymphoma
por: Yang, Jing, et al.
Publicado: (2019)

Prognostic Significance of Systemic Immune-Inflammation Index in Patients With Diffuse Large B-Cell Lymphoma
por: Wang, Zanzan, et al.
Publicado: (2021)

Clinical Features and Prognostic Significance of NOTCH1 Mutations in Diffuse Large B-Cell Lymphoma
por: Li, Zhongqi, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ia5ld3gec7n8fkvp0s1fvicg17